Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in salivary gland carcinoma
2012-004408-36Phase 2Completed
- Sponsor
- Unicancer
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pazopanib in salivary gland cancer (SGC), sponsored by Unicancer. Started Jun 2013; status: completed.
02
Drugs
pazopanib
03
Conditions
salivary gland cancer (SGC)
Beyond the preview
Go deeper on 2012-004408-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004408-36.